Open AccessEffective Treatment of NSCLC with Surgery After Nivolumab Combined with Chemotherapy: A Case Report and Brief Review of the Literature
Author(s) -
Liangchen Zhao,
Lu-Zhen Li,
Ting Chen,
Cong Fang
Publication year - 2020
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s266155
Subject(s) - nivolumab , medicine , lung cancer , lymph node , chemotherapy , dissection (medical) , mediastinal lymph node , radiology , paclitaxel , cisplatin , oncology , surgery , cancer , immunotherapy , metastasis
Immuno checkpoint inhibitors (ICIs) including anti-PD-L1 antibody have shown certain therapeutic effects on various cancer types. Here, we reported a case of the patient with resectable non-small cell lung cancer (NSCLC) showing a complete response to nivolumab combined with chemotherapy.